Hernández, Patricia <br/><br/>
Therapeutic Targeting of CD6 in Autoimmune Diseases: A Review of Cuban Clinical Studies with the Antibodies IOR-T1 and Itolizumab.  [electronic resource] 

 -  Current drug targets  2016 
 - 666-77 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1873-5592 
<br/><br/><label>Standard No.: </label>10.2174/1389450117666160201114308  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibodies, Monoclonal--pharmacology<br/>Antibodies, Monoclonal, Humanized--pharmacology<br/>Antigens, CD--metabolism<br/>Antigens, Differentiation, T-Lymphocyte--metabolism<br/>Autoimmune Diseases--drug therapy<br/>Cell Adhesion Molecules, Neuronal--metabolism<br/>Clinical Trials as Topic<br/>Cuba<br/>Fetal Proteins--metabolism<br/>Humans<br/>Mice<br/>Protein Binding--drug effects<br/>Treatment Outcome